{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:35:37Z","timestamp":1787024137220,"version":"build-2736575974"},"reference-count":47,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2019]]},"DOI":"10.2131\/jts.44.145","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T17:37:17Z","timestamp":1551893837000},"page":"145-153","source":"Crossref","is-referenced-by-count":8,"title":["Effect of the metabolic capacity in rat liver S9 on the positive results of &lt;i&gt;in vitro&lt;\/i&gt; micronucleus tests"],"prefix":"10.2131","volume":"44","author":[{"given":"Yuki","family":"Kishino","sequence":"first","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Shibaya","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamoto","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aeschbacher, H.U., Meier, H. and Jaccaud, E. (1986): The effect of caffeine in the <i>in vivo<\/i> SCE and micronucleus mutagenicity tests. Mutat. Res., <b>174<\/b>, 53-58.","DOI":"10.1016\/0165-7992(86)90076-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ames, B.N., Durston, W.E., Yamasaki, E. and Lee, F.D. (1973): Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA, <b>70<\/b>, 2281-2285.","DOI":"10.1073\/pnas.70.8.2281"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ames, B.N., Mccann, J. and Yamasaki, E. (1975): Methods for detecting carcinogens and mutagens with the Salmonella\/mammalian-microsome mutagenicity test. Mutat. Res., <b>31<\/b>, 347-364.","DOI":"10.1016\/0165-1161(75)90046-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Api, A.M. (2001): Lack of effect of coumarin on the formation of micronuclei in an <i>in vivo<\/i> mouse micronucleus assay. Food Chem. Toxicol., <b>39<\/b>, 837-841.","DOI":"10.1016\/S0278-6915(01)00024-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Born, S.L., Caudill, D., Fliter, K.L. and Purdon, M.P. (2002): Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab. Dispos., <b>30<\/b>, 483-487.","DOI":"10.1124\/dmd.30.5.483"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Brambilla, G. and Martelli, A. (2009): Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. Mutat. Res., <b>681<\/b>, 209-229.","DOI":"10.1016\/j.mrrev.2008.09.002"},{"key":"7","unstructured":"Clarke, L. and Waxman, D.J. (1989): Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res., <b>49<\/b>, 2344-2350."},{"key":"8","doi-asserted-by":"crossref","unstructured":"De Flora, S., Russo, P., Pala, M., Fassina, G., Zunino, A., Bennicelli, C., Zanacchi, P., Camoirano, A. and Parodi, S. (1985): Assay of phenacetin genotoxicity using <i>in vitro<\/i> and <i>in vivo<\/i> test systems. J. Toxicol. Environ. Health, <b>16<\/b>, 355-377.","DOI":"10.1080\/15287398509530747"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Edwards, A.J., Price, R.J., Renwick, A.B. and Lake, B.G. (2000): Lack of effect of coumarin on unscheduled DNA synthesis in the <i>in vivo<\/i> rat hepatocyte DNA repair assay. Food Chem. Toxicol., <b>38<\/b>, 403-409.","DOI":"10.1016\/S0278-6915(00)00016-8"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Guengerich, F.P., Dannan, G.A., Wright, S.T., Martin, M.V. and Kaminsky, L.S. (1982): Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry, <b>21<\/b>, 6019-6030.","DOI":"10.1021\/bi00266a045"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Guengerich, F.P. (2003): Cytochromes P450, drugs, and diseases. Mol. Interv., <b>3<\/b>, 194-204.","DOI":"10.1124\/mi.3.4.194"},{"key":"12","unstructured":"Gris, J.H., Dragonetti, M.A., Fern\u00e1ndez, B.M. and Sicardi, S.M. (2008): Evaluation of the mutagenic potential of piroxicam, meloxicam and their precursors using <i>in vivo<\/i> micronucleus test. Inf. Tecnol., <b>19<\/b>, 83-88."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hakura, A., Suzuki, S., Sawada, S., Sugihara, T., Hori, Y., Uchida, K., Kerns, W.D., Sagami, F., Motooka, S. and Satoh, T. (2003): Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors. Regul. Toxicol. Pharmacol., <b>37<\/b>, 20-27.","DOI":"10.1016\/S0273-2300(02)00024-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hashizume, T., Yoshitomi, S., Asahi, S., Matsumura, S., Chatani, F. and Oda, H. (2009): In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation. Mutat. Res., <b>677<\/b>, 1-7.","DOI":"10.1016\/j.mrgentox.2009.03.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Higashikuni, N., Baba, T., Nakamura, T. and Sutou, S. (1992): The micronucleus test with peripheral reticulocytes from phenacetin-treated mice. Mutat. Res., <b>278<\/b>, 159-164.","DOI":"10.1016\/0165-1218(92)90227-Q"},{"key":"16","unstructured":"Hobbs, D.C. and Twomey, T.M. (1981): Metabolism of piroxicam by laboratory animals. Drug Metab. Dispos., <b>9<\/b>, 114-118."},{"key":"17","unstructured":"ICH Harmonised tripartite guideline. (2011): Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). Available at: http:\/\/www.ich.org\/products\/guidelines\/safety\/article\/safety-guidelines.html."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ishidate, M. Jr., Harnois, M.C. and Sofuni, T. (1988): A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res., <b>195<\/b>, 151-213.","DOI":"10.1016\/0165-1110(88)90023-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Johansson, S.L. (1981): Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen). Int. J. Cancer, <b>27<\/b>, 521-529.","DOI":"10.1002\/ijc.2910270416"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Joss\u00e9, R., Rogue, A., Lorge, E. and Guillouzo, A. (2012): An adaptation of the human HepaRG cells to the <i>in vitro<\/i> micronucleus assay. Mutagenesis, <b>27<\/b>, 295-304.","DOI":"10.1093\/mutage\/ger076"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kirkland, D., Aardema, M., Henderson, L. and M\u00fcller, L. (2005): Evaluation of the ability of a battery of three <i>in vitro<\/i> genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res., <b>584<\/b>, 1-256.","DOI":"10.1016\/j.mrgentox.2005.02.004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., Kasper, P., Kirchner, S., Lynch, A., Marzin, D., Maurici, D., Meunier, J.R., M\u00fcller, L., Nohynek, G., Parry, J., Parry, E., Thybaud, V., Tice, R., Van Benthem, J., Vanparys, P. and White, P. (2007): How to reduce false positive results when undertaking <i>in vitro<\/i> genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res., <b>628<\/b>, 31-55.","DOI":"10.1016\/j.mrgentox.2006.11.008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Knasm\u00fcller, S., Schwab, C.E., Land, S.J., Wang, C.Y., Sanyal, R., Kundi, M., Parzefall, W. and Darroudi, F. (1999): Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. Mutagenesis, <b>14<\/b>, 533-540.","DOI":"10.1093\/mutage\/14.6.533"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Ku, W.W., Bigger, A., Brambilla, G., Glatt, H., Gocke, E., Guzzie, P.J., Hakura, A., Honma, M., Martus, H.J., Obach, R.S. and Roberts, S.; Strategy Expert Group, IWGT. (2007): Strategy for genotoxicity testing\u2013metabolic considerations. Mutat. Res., <b>627<\/b>, 59-77.","DOI":"10.1016\/j.mrgentox.2006.10.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Matsubara, T., Otsubo, S., Yoshihara, E. and Touchi, A. (1983): Biotransformation of coumarin derivatives. (2). Oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and a simple assay procedure for 7-alkoxycoumarin O-dealkylase. Jpn. J. Pharmacol., <b>33<\/b>, 41-56.","DOI":"10.1254\/jjp.33.41"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Matsuoka, A., Hayashi, M. and Ishidate, M. Jr. (1979): Chromosomal aberration tests on 29 chemicals combined with S9 mix <i>in vitro.<\/i> Mutat. Res., <b>66<\/b>, 277-290.","DOI":"10.1016\/0165-1218(79)90089-2"},{"key":"27","unstructured":"McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990): Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., <b>50<\/b>, 3367-3376."},{"key":"28","unstructured":"National Toxicology Program. Available at: http:\/\/ntp.niehs.nih.gov\/"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Nomura, A., Sakurai, E. and Hikichi, N. (1997): Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes. J. Pharm. Pharmacol., <b>49<\/b>, 257-262.","DOI":"10.1111\/j.2042-7158.1997.tb06791.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Okada, E., Fujiishi, Y., Narumi, K., Yasutake, N. and Ohyama, W. (2013): A four-day oral treatment regimen for simultaneous micronucleus analyses in the glandular stomach, colon, and bone marrow of rats. Mutat. Res., <b>758<\/b>, 87-94.","DOI":"10.1016\/j.mrgentox.2013.10.002"},{"key":"31","unstructured":"Omura, T. and Sato, R. (1964): The carbon monoxide-binding pigment of liver microsomes 1. Evidence for its hemoprotein nature. J. Biol. Chem., <b>239<\/b>, 2370-2378."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Paolini, M. and Cantelli-Forti, G. (1997): On the metabolizing systems for short-term genotoxicity assays: a review. Mutat. Res., <b>387<\/b>, 17-34.","DOI":"10.1016\/S1383-5742(97)00020-3"},{"key":"33","unstructured":"Pearce, R.E., Rodrigues, A.D., Goldstein, J.A. and Parkinson, A. (1996): Identification of the human P450 enzymes involved in lansoprazole metabolism. J. Pharmacol. Exp. Ther., <b>277<\/b>, 805-816."},{"key":"34","first-page":"499","year":"1991","unstructured":"Peters, M.M., Walters, D.G., van Ommen, B., van Bladeren, P.J. and Lake, B.G. (1991): Effect of inducers of cytochrome P-450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes. Xenobiotica, <b>21<\/b>, 499-514.","journal-title":"Xenobiotica","ISSN":"https:\/\/id.crossref.org\/issn\/0049-8254","issn-type":"print"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Shah, U.K., Mallia, J.O., Singh, N., Chapman, K.E., Doak, S.H. and Jenkins, G.J. (2018): A three-dimensional <i>in vitro<\/i> HepG2 cells liver spheroid model for genotoxicity studies. Mutat. Res., <b>825<\/b>, 51-58.","DOI":"10.1016\/j.mrgentox.2017.12.005"},{"key":"36","unstructured":"Shirai, T., Sano, M., Tamano, S., Takahashi, S., Hirose, M., Futakuchi, M., Hasegawa, R., Imaida, K., Matsumoto, K., Wakabayashi, K., Sugimura, T. and Ito, N. (1997): The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-<i>b<\/i>]pyridine (PhIP) derived from cooked foods. Cancer Res., <b>57<\/b>, 195-198."},{"key":"37","unstructured":"Tang, W., Stearns, R.A., Bandiera, S.M., Zhang, Y., Raab, C., Braun, M.P., Dean, D.C., Pang, J., Leung, K.H., Doss, G.A., Strauss, J.R., Kwei, G.Y., Rushmore, T.H., Chiu, S.H. and Baillie, T.A. (1999): Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites. Drug Metab. Dispos., <b>27<\/b>, 365-372."},{"key":"38","unstructured":"Tassaneeyakul, W., Birkett, D.J., Veronese, M.E., McManus, M.E., Tukey, R.H., Quattrochi, L.C., Gelboin, H.V. and Miners, J.O. (1993): Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther., <b>265<\/b>, 401-407."},{"key":"39","doi-asserted-by":"crossref","unstructured":"Thomas, P.E., Reik, L.M., Ryan, D.E. and Levin, W. (1983): Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J. Biol. Chem., <b>258<\/b>, 4590-4598.","DOI":"10.1016\/S0021-9258(18)32664-4"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Thybaud, V., Aardema, M., Clements, J., Dearfield, K., Galloway, S., Hayashi, M., Jacobson-Kram, D., Kirkland, D., MacGregor, J.T., Marzin, D., Ohyama, W., Schuler, M., Suzuki, H. and Zeiger, E.; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing. (2007): Strategy for genotoxicity testing: hazard identification and risk assessment in relation to <i>in vitro<\/i> testing. Mutat. Res., <b>627<\/b>, 41-58.","DOI":"10.1016\/j.mrgentox.2006.10.003"},{"key":"41","unstructured":"TOXNET TOXICOLOGY DATA NETWORK. Available at https:\/\/toxnet.nlm.nih.gov"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Vassallo, J.D., Hicks, S.M., Daston, G.P. and Lehman-McKeeman, L.D. (2004): Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity. Toxicol. Sci., <b>80<\/b>, 249-257.","DOI":"10.1093\/toxsci\/kfh162"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Yamamura, E., Aruga, C., Muto, S., Baba, N. and Uno, Y. (2018): Correlation between the results of <i>in vitro<\/i> and <i>in vivo<\/i> chromosomal damage tests in consideration of exposure levels of test chemicals. Genes Environ., <b>40<\/b>, 6.","DOI":"10.1186\/s41021-018-0094-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Yan, Z., Li, J., Huebert, N., Caldwell, G.W., Du, Y. and Zhong, H. (2005): Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides. Drug Metab. Dispos., <b>33<\/b>, 706-713.","DOI":"10.1124\/dmd.104.003095"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Yasuda, S.U., Zannikos, P., Young, A.E., Fried, K.M., Wainer, I.W. and Woosley, R.L. (2002): The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Br. J. Clin. Pharmacol., <b>53<\/b>, 519-525.","DOI":"10.1046\/j.1365-2125.2002.01578.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Youssef, A.F., Turck, P. and Fort, F.L. (2003): Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity. Reprod. Toxicol., <b>17<\/b>, 109-116.","DOI":"10.1016\/S0890-6238(02)00099-0"},{"key":"47","unstructured":"Yu, L.J., Drewes, P., Gustafsson, K., Brain, E.G., Hecht, J.E. and Waxman, D.J. (1999): In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity. J. Pharmacol. Exp. Ther., <b>288<\/b>, 928-937."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/3\/44_145\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T23:05:54Z","timestamp":1663023954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/3\/44_145\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.44.145","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}